MAPS finalizes agreement with the University of Alabama at Birmingham for an inhaled cannabis PTSD clinical trial in veterans

MAPS has finalized a clinical trial agreement with the University of Alabama at Birmingham, establishing UAB as the first official site for the MJP2 study. The study will investigate inhaled cannabis as a treatment for post-traumatic stress disorder in U.S. military veterans. Funding comes from the Veterans Marijuana Research grant program of the State of Michigan. The UAB site will be administered by Alec Owens, PhD, Assistant Professor in the Heersink School of Medicine, and Peter Hendricks, PhD, Professor of Psychiatry. The supplied announcement confirms the institutional partnership, study population, intervention, funding source, and site leadership, but provides no details about the trial design, sample size, outcomes, or timeline.